Kidney Transplantation Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Evaluation of the Prophylactic Use of Letermovir in Kidney Transplant Recipients at Risk of Cytomegalovirus Infection
Conditions: CMV Infection Interventions: Drug: Letermovir 480 MG; Drug: Ganciclovir Sponsors: Hospital do Rim e Hipertens ão Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 2, 2024 Category: Research Source Type: clinical trials

Quantiferon CMV to Identify Treatment Need For Asymptomatic CMV Infection After Solid Organ Transplant (QUANTIFOT)
Conditions: Solid Organ Transplantation (Heart, Kidney, Lung, Liver); Cytomegalovirus Infections Interventions: Diagnostic Test: Quantiferon CMV (assay that determine the presence of CMV-specific T lymphocytes).; Other: Communication of the result of the QF-CMV to the clinician in charge Sponsors: University Hospital, Grenoble Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 2, 2024 Category: Research Source Type: clinical trials

Molecular Landscape of Microvascular Inflammation in Kidney Allografts
Conditions: Kidney Rejection Transplant Interventions: Other: No intervention Sponsors: Paris Translational Research Center for Organ Transplantation Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 2, 2024 Category: Research Source Type: clinical trials

Neohepatic Albumin-Bilirubin Scores on Renal Outcomes in Living-donor Liver Transplantation Recipients
Conditions: Acute Kidney Injury; Chronic Kidney Diseases; Graft Failure Sponsors: Asan Medical Center Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 1, 2024 Category: Research Source Type: clinical trials

Deceased Donor Bladder or Combined Kidney-bladder Transplantation: a Phase 0 First-in-human Study
Conditions: Bladder Disease; Bladder, Neurogenic; Bladder Cancer; Kidney Failure Interventions: Procedure: Bladder Transplantation; Procedure: Combined Kidney and Bladder Transplantation Sponsors: University of California, Los Angeles Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 29, 2024 Category: Research Source Type: clinical trials

Use of DNA Testing and Gene Expression Profiling to Help Transition Kidney Transplant Recipients to Belatacept-only Immunosuppression
Conditions: Kidney Transplant Immunosuppression Interventions: Diagnostic Test: Allosure and TruGraf Sponsors: University of Texas Southwestern Medical Center Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 29, 2024 Category: Research Source Type: clinical trials

Evaluation of an Internet Based Education and Support Program for Patients Awaiting Kidney Transplantation
Conditions: Chronic Kidney Diseases Interventions: Behavioral: Internet based education and support program for patients awaiting kidney transplantation Sponsors: Linkoeping University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 27, 2024 Category: Research Source Type: clinical trials

CAPABLE Transplant
Conditions: Quality of Life; Depression; End Stage Renal Disease; Disability Physical Interventions: Behavioral: CAPABLE Transplant- Open Label Pilot; Behavioral: CAPABLE Transplant- Randomized Control Trial Sponsors: Johns Hopkins University; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 22, 2024 Category: Research Source Type: clinical trials

Tocilizumab in chronic active antibody-mediated rejection: rationale and protocol of an in-progress randomized controlled open-label multi-center trial (INTERCEPT study)
DiscussionNo effective treatment exists for caAMR at present. Based on the hypothesis that inhibition of IL-6 receptor by tocilizumab will reduce antibody production and reduce antibody-mediated damage, our randomized trial has a potential to provide evidence for a novel treatment strategy for caAMR, therewith slowing the decline in graft function in the long-term.Trial registrationClinicalTrials.gov NCT04561986. Registered on September 24, 2020 (Source: Trials)
Source: Trials - March 22, 2024 Category: Research Source Type: clinical trials

HI-Bio Receives FDA Orphan Drug Designation for Felzartamab for the Treatment of Antibody-Mediated Rejection (AMR) in Kidney Transplant Recipients
SOUTH SAN FRANCISCO, Calif.,– March 21, 2024– Human Immunology Biosciences (HI-Bio™), a clinical-stage biotechnology company developing targeted therapies for patients with severe immune-mediated diseases (IMDs), today announced... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - March 21, 2024 Category: Pharmaceuticals Source Type: clinical trials

Analysis of the Effect of Donor CYP3A5 Gene Polymorphism on Early Tacrolimus Concentration and Postoperative Acute Renal Injury After Liver Transplantation
Conditions: Complete and Accurate Statistical Data of 60 Patients; CYP3A5*3 Genotypes of 60 Donors and Recipients Were Analyzed Accurately; Postoperative Tacrolimus Concentrations Were Accurately Recorded in 60 Patients; According to the Diagnosis and Grading Criteria of Acute Kidney Injury, the Cases and Grading of Postoperative Acute Kidney Injury in 60 Patients Were Counted; Scientific and Rigorous Statistical Analysis of Data Interventions: Other: CYP3A5*1* 、CYP3A5*1*3; Other: CYP3A5*3*3 Sponsors: Ziqiang Li Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 20, 2024 Category: Research Source Type: clinical trials

Rakt outcome analysis
Conditions: Kidney Transplantation; Robotic Surgery Sponsors: Seoul National University Hospital Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 20, 2024 Category: Research Source Type: clinical trials

Impact of Glycemic Control After Reperfusion on Acute Kidney Injury in Living Donor Liver Transplantation
Conditions: Acute Kidney Injury; Hyperglycemia; Hypoglycemia; End Stage Liver Disease Interventions: Other: Observational study, records of blood glucose level after reperfusion Sponsors: Asan Medical Center Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 20, 2024 Category: Research Source Type: clinical trials

Australian Genomics Of Chronic Allograft Dysfunction Study
Conditions: Kidney Transplant Rejection; Kidney Transplant; Complications Sponsors: Western Sydney Local Health District Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 15, 2024 Category: Research Source Type: clinical trials

Viral Immunity in Solid Organ Transplant Recipients: Monitoring Of The Response To Hepatitis B Booster Vaccination
Conditions: HBV; Kidney Transplantation; Liver Transplantation Interventions: Drug: Tacrolimus; Drug: Belatacept Sponsors: University Hospital, Grenoble; National Agency for Research on AIDS and Viral Hepatitis (ANRS) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 13, 2024 Category: Research Source Type: clinical trials